Details of the Drug Reposition

General Information of This Drug (ID: DMD709J)

Drug Name
RM-131   DMD709J
Synonyms Relamorelin
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastroparesis DISDW0SR DA41.00 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cachexia DIS4W15K MG20 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03426345) Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT02357420) A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis. U.S. National Institutes of Health.